Publications by authors named "S Genzor"
Purpose: Chronic obstructive pulmonary disease (COPD) is a prevalent and preventable condition that typically worsens over time. Acute exacerbations of COPD significantly impact disease progression, underscoring the importance of prevention efforts. This observational study aimed to achieve two main objectives: (1) identify patients at risk of exacerbations using an ensemble of clustering algorithms, and (2) classify patients into distinct clusters based on disease severity.
View Article and Find Full Text PDFAnxiety in Patients with Post-COVID Syndrome: Associated Factors.
Psychol Res Behav Manag
September 2024
Article Synopsis
- The text talks about "post-COVID-19 syndrome," which means people can have symptoms like tiredness and pain even after they recover from COVID-19.
- A study looked at 1,756 patients who visited a clinic for help after COVID-19, checking their symptoms, anxiety levels, and lung function.
- The results showed younger women often felt more anxious, while those who had been in the hospital had less anxiety, and better lung function helped reduce anxiety too.
Article Synopsis
- The study investigates the long-term effects of BiPAP therapy on heart function in patients with obesity hypoventilation syndrome (OHS), as these effects are not well understood.
- Thirteen patients participated, and after 3 and 12 months of BiPAP treatment, significant improvements in heart metrics like stroke volume and ejection time were observed, alongside reduced levels of inflammatory markers.
- Overall, the results indicate that BiPAP therapy can enhance cardiac function and decrease inflammation in patients with chronic OHS over a year of treatment.
The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement.
Pneumonia (Nathan)
February 2024
Rationale: Persistent respiratory symptoms following Coronavirus Disease 2019 (COVID-19) are associated with residual radiological changes in lung parenchyma, with a risk of development into lung fibrosis, and with impaired pulmonary function. Previous studies hinted at the possible efficacy of corticosteroids (CS) in facilitating the resolution of post-COVID residual changes in the lungs, but the available data is limited.
Aim: To evaluate the effects of CS treatment in post-COVID respiratory syndrome patients.
Corticosteroid treatment prediction using chest X-ray and clinical data.
Comput Struct Biotechnol J
December 2024
Background And Objective: Severe courses of COVID-19 disease can lead to long-term complications. The post-acute phase of COVID-19 refers to the persistent or new symptoms. This problem is becoming more relevant with the increasing number of patients who have contracted COVID-19 and the emergence of new virus variants.
View Article and Find Full Text PDF